262 related articles for article (PubMed ID: 2280190)
1. Apolipoprotein E distribution among human plasma lipoproteins: role of the cysteine-arginine interchange at residue 112.
Weisgraber KH
J Lipid Res; 1990 Aug; 31(8):1503-11. PubMed ID: 2280190
[TBL] [Abstract][Full Text] [Related]
2. Human apolipoprotein E. Role of arginine 61 in mediating the lipoprotein preferences of the E3 and E4 isoforms.
Dong LM; Wilson C; Wardell MR; Simmons T; Mahley RW; Weisgraber KH; Agard DA
J Biol Chem; 1994 Sep; 269(35):22358-65. PubMed ID: 8071364
[TBL] [Abstract][Full Text] [Related]
3. Abnormal in vivo metabolism of apolipoprotein E4 in humans.
Gregg RE; Zech LA; Schaefer EJ; Stark D; Wilson D; Brewer HB
J Clin Invest; 1986 Sep; 78(3):815-21. PubMed ID: 3745440
[TBL] [Abstract][Full Text] [Related]
4. Human apolipoprotein E4 domain interaction. Arginine 61 and glutamic acid 255 interact to direct the preference for very low density lipoproteins.
Dong LM; Weisgraber KH
J Biol Chem; 1996 Aug; 271(32):19053-7. PubMed ID: 8702576
[TBL] [Abstract][Full Text] [Related]
5. Contributions of the carboxyl-terminal helical segment to the self-association and lipoprotein preferences of human apolipoprotein E3 and E4 isoforms.
Sakamoto T; Tanaka M; Vedhachalam C; Nickel M; Nguyen D; Dhanasekaran P; Phillips MC; Lund-Katz S; Saito H
Biochemistry; 2008 Mar; 47(9):2968-77. PubMed ID: 18201068
[TBL] [Abstract][Full Text] [Related]
6. Molecular basis for the differences in lipid and lipoprotein binding properties of human apolipoproteins E3 and E4.
Nguyen D; Dhanasekaran P; Nickel M; Nakatani R; Saito H; Phillips MC; Lund-Katz S
Biochemistry; 2010 Dec; 49(51):10881-9. PubMed ID: 21114327
[TBL] [Abstract][Full Text] [Related]
7. Evidence for differential effects of apoE3 and apoE4 on HDL metabolism.
Hopkins PC; Huang Y; McGuire JG; Pitas RE
J Lipid Res; 2002 Nov; 43(11):1881-9. PubMed ID: 12401887
[TBL] [Abstract][Full Text] [Related]
8. Stable expression and secretion of apolipoproteins E3 and E4 in mouse neuroblastoma cells produces differential effects on neurite outgrowth.
Bellosta S; Nathan BP; Orth M; Dong LM; Mahley RW; Pitas RE
J Biol Chem; 1995 Nov; 270(45):27063-71. PubMed ID: 7592957
[TBL] [Abstract][Full Text] [Related]
9. Plasma ApoE4 Levels Are Lower than ApoE2 and ApoE3 Levels, and Not Associated with Plasma Aβ40/42 Ratio as a Biomarker of Amyloid-β Amyloidosis in Alzheimer's Disease.
Nakamura T; Kawarabayashi T; Ueda T; Shimomura S; Hoshino M; Itoh K; Ihara K; Nakaji S; Takatama M; Ikeda Y; Shoji M
J Alzheimers Dis; 2023; 93(1):333-348. PubMed ID: 36970894
[TBL] [Abstract][Full Text] [Related]
10. [Distribution of the apolipoprotein-E and -E-complexes in lipoproteins of human serum with the apolipoprotein-E4/E3 phenotype].
Hidaka H; Tozuka M; Yamauchi K; Sugano M; Nakabayashi T; Katsuyama T
Rinsho Byori; 1997 Dec; 45(12):1172-6. PubMed ID: 9437899
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders.
Mahley RW
J Mol Med (Berl); 2016 Jul; 94(7):739-46. PubMed ID: 27277824
[TBL] [Abstract][Full Text] [Related]
12. Introduction of human apolipoprotein E4 "domain interaction" into mouse apolipoprotein E.
Raffai RL; Dong LM; Farese RV; Weisgraber KH
Proc Natl Acad Sci U S A; 2001 Sep; 98(20):11587-91. PubMed ID: 11553788
[TBL] [Abstract][Full Text] [Related]
13. Redox equilibrium of serum apolipoprotein E3: a buffering effect of disulfide-linked complexes against oxidative stress on apolipoprotein E3-containing lipoproteins.
Yamauchi K; Iwasaki S; Kawakami Y
Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30948502
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E isoforms and lipoprotein metabolism.
Phillips MC
IUBMB Life; 2014 Sep; 66(9):616-23. PubMed ID: 25328986
[TBL] [Abstract][Full Text] [Related]
15. Electrophoretic analysis of oxidative modification of apolipoprotein E in very low density lipoprotein from fresh human plasma.
Kashiwagi S; Nakamura K; Arai H; Yamashita H; Ito H
Electrophoresis; 1999 Jun; 20(7):1418-24. PubMed ID: 10424464
[TBL] [Abstract][Full Text] [Related]
16. Differential cellular accumulation/retention of apolipoprotein E mediated by cell surface heparan sulfate proteoglycans. Apolipoproteins E3 and E2 greater than e4.
Ji ZS; Pitas RE; Mahley RW
J Biol Chem; 1998 May; 273(22):13452-60. PubMed ID: 9593678
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the LDL-receptor binding of VLDL and LDL from apoE4 and apoE3 homozygotes.
Mamotte CD; Sturm M; Foo JI; van Bockxmeer FM; Taylor RR
Am J Physiol; 1999 Mar; 276(3):E553-7. PubMed ID: 10070023
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E in lipoprotein metabolism, health and cardiovascular disease.
Marais AD
Pathology; 2019 Feb; 51(2):165-176. PubMed ID: 30598326
[TBL] [Abstract][Full Text] [Related]
19. Lipoproteins produced by ApoE-/- astrocytes infected with adenovirus expressing human ApoE.
Peng D; Song C; Reardon CA; Liao S; Getz GS
J Neurochem; 2003 Sep; 86(6):1391-402. PubMed ID: 12950448
[TBL] [Abstract][Full Text] [Related]
20. Interaction of nascent ApoE2, ApoE3, and ApoE4 isoforms expressed in mammalian cells with amyloid peptide beta (1-40). Relevance to Alzheimer's disease.
Aleshkov S; Abraham CR; Zannis VI
Biochemistry; 1997 Aug; 36(34):10571-80. PubMed ID: 9265639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
